Daniel K Wells

5PUBLICATIONS
71CO-AUTHORS
Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 15, 2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.

Andras Heczey, Xin Xu, Amy N Courtney

|Mar 01, 2022
Bystander T cells in cancer immunology and therapy.

Stefanie L Meier, Ansuman T Satpathy, Daniel K Wells

|Dec 22, 2021
TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion.

Mojdeh Shakiba, Paul Zumbo, Gabriel Espinosa-Carrasco

Pageof 1